A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

NCT03009981 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

504

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Apalutamide
DRUG: LHRH Analogue
DRUG: Abiraterone Acetate
DRUG: Prednisone

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]